Adaptimmune Therapeutics PLC (ADAPY) EV to CFO (2021 - 2022)
Adaptimmune Therapeutics' (ADAPY) EV to CFO stood at 591.51 in Q1 2022, up 101.7% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) EV to CFO (2021 - 2022) Analysis & Trends
On a TTM basis, Adaptimmune Therapeutics' EV to CFO came in at 279.42 as of Mar 31, 2022; for FY2021, it came in at 293.24.
Peer Set
Peer Comparison
API Access
Adaptimmune Therapeutics PLC EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();